Ann: INOVIQ detects 19% more breast cancers than leading test, page-82

@charttrader I doubt the company are out seeking funds while the results are pending / imminent for Ovarian cancer . That would be in dangerous territory imo. I think more likely a raise will occur sometime after they are announced as intimated by DW in his intro speech. Hopefully that would support a higher offer and less dilution and based on an exciting proposition . Who are the insiders you claim are selling. ? Volume on the drop seemed pretty insignificant to me and not evidence of a large fundie dropping hints to clients . But hey this is the ASX!